COMPARISON OF RENAL DYSFUNCTION IN SYSTOLIC HEART FAILURE PATIENTS TREATED WITH SACUBITRIL-VALSARTAN OR ACE INHIBITOR/ANGIOTENSIN RECEPTOR BLOCKER

被引：1
|
作者：
Tan, Nicholas [1 ]
Deng, Yihong [1 ]
Yao, Xiaoxi [1 ]
Sangaralingham, LIndsey [1 ]
Shah, Nilay [1 ]
Rule, Andrew [1 ]
Burnett, John [1 ]
Dunlay, Shannon [1 ]
Sangaralingham, Jeson [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2020年 / 75卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1415-77
引用
收藏
页码：1023 / 1023
页数：1
相关论文
共 50 条
  • [21] Eligibility criteria for Sacubitril-Valsartan in patients admitted for heart failure: the real world
    David Cabrita Roque, D.
    Augusto, J.
    Santos, M.
    Candeias Faria, D.
    Baltazar Ferreira, J.
    Sacchetti, A.
    Melo, L.
    Oliveira Soares, A.
    Morais, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 477 - 478
  • [22] Use and Out-of-Pocket Cost of Sacubitril-Valsartan in Patients With Heart Failure
    Shore, Supriya
    Basu, Tanima
    Kamdar, Neil
    Brady, Patrick
    Birati, Edo
    Hummel, Scott L.
    Chopra, Vineet
    Nallamothu, Brahmajee K.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (17):
  • [23] TOLERABILITY OF SACUBITRIL-VALSARTAN IN PATIENTS WITH CANCER AND HEART FAILURE WITH REDUCED EJECTION FRACTION
    Yarrabothula, Akshitha R.
    Alsheikh-Kassim, Mohammad
    Amatullah, Atia
    Fossas, Jose
    Salman, Justin
    Seal, Zachary
    Lin, Heather
    Irizarry-Caro
    Wanna, Charles
    Miller, Chase
    Fatakdawala, Mariya
    Palaskas, Nicolas L.
    Deswal, Anita
    Koutroumpakis, Efstratios
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2325 - 2325
  • [24] Clinical benefit of sacubitril-valsartan in patients with heart failure with reduced ejection fraction
    Spinoni, Enrico Guido
    Lio, Veronica
    Degiovanni, Anna
    Erbetta, Riccardo
    Marino, Paolo
    Patti, Giuseppe
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N101 - N101
  • [25] Echocardiographic evaluation of the effects of sacubitril-valsartan on vascular properties in heart failure patients
    Karagodin, Ilya
    Kalantari, Sara
    Yu, Dong Bo
    Kim, Gene
    Sayer, Gabriel
    Addetia, Karima
    Tayazime, Sarah
    Weinert, Lynn
    Yamat, Megan
    Uriel, Nir
    Lang, Roberto
    Mor-Avi, Victor
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2020, 36 (02): : 271 - 278
  • [26] Sex Differences in the Effectiveness of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Sacubitril-Valsartan for the Treatment of Heart Failure
    Sohani, Zahra N. N.
    Behlouli, Hassan
    de Moura, Cristiano Soares
    Abrahamowicz, Michal
    Pilote, Louise
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (14):
  • [27] Attenuation of heart failure due to coronary stenosis by ACE inhibitor and angiotensin receptor blocker
    Sato, H
    Yaoita, H
    Maehara, K
    Maruyama, Y
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (01): : H359 - H368
  • [28] Transition from angiotensin-converting enzyme inhibitor/angiotensin-II-receptor-blocker to sacubitril/valsartan in chronic heart failure patients: Initial experiences in clinical practice
    Hlavata, Katerina
    Hoskova, Lenka
    Franekova, Janka
    Jabor, Antonin
    Kautzner, Josef
    Melenovsky, Vojtech
    Benes, Jan
    COR ET VASA, 2018, 60 (03) : E209 - E214
  • [29] Comparative Effectiveness of Sacubitril-Valsartan Versus ACE/ARB Therapy in Heart Failure With Reduced Ejection Fraction
    Tan, Nicholas Y.
    Sangaralingham, Lindsey R.
    Sangaralingham, S. Jeson
    Yao, Xiaoxi
    Shah, Nilay D.
    Dunlay, Shannon M.
    JACC-HEART FAILURE, 2020, 8 (01) : 43 - 54
  • [30] Systolic blood pressure and safety of sacubitril/valsartan in patients with heart failure
    Kanaoka, K. Koshiro
    Iwanaga, Y.
    Miyamoto, Y.
    Matsumoto, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 406 - 406
12345